NGDN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.659800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.650200E-01
Normal-vs-Stage2
6.717200E-01
Normal-vs-Stage3
2.103800E-01
Normal-vs-Stage4
9.019600E-01
Stage1-vs-Stage2
7.365200E-01
Stage1-vs-Stage3
3.166600E-01
Stage1-vs-Stage4
7.244800E-01
Stage2-vs-Stage3
8.606000E-02
Stage2-vs-Stage4
7.969800E-01
Stage3-vs-Stage4
3.143400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.048600E-01
Normal-vs-AfricanAmerican
5.222400E-01
Normal-vs-Asian
3.062600E-01
Caucasian-vs-AfricanAmerican
7.052200E-01
Caucasian-vs-Asian
5.014000E-01
AfricanAmerican-vs-Asian
8.908200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.554200E-01
Normal-vs-Female
6.897600E-01
Male-vs-Female
9.158000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.906600E-01
Normal-vs-Age(41-60Yrs)
9.482800E-01
Normal-vs-Age(61-80Yrs)
5.210600E-01
Normal-vs-Age(81-100Yrs)
9.305200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.062400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.978600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.166200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.794100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.654000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.632620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.376000E-01
Normal-vs-Daily Drinker
8.952800E-01
Normal-vs-Weekly Drinker
7.459000E-01
Normal-vs-Occasional Drinker
8.224400E-01
Normal-vs-Social Drinker
4.060000E-01
Non Drinker-vs-Daily Drinker
2.661400E-01
Non Drinker-vs-Weekly Drinker
6.313400E-01
Non Drinker-vs-Occasional Drinker
1.978370E-01
Non Drinker-vs-Social Drinker
6.827000E-01
Daily Drinker-vs-Weekly Drinker
6.985600E-01
Daily Drinker-vs-Occasional Drinker
9.914000E-01
Daily Drinker-vs-Social Drinker
4.548600E-01
Weekly Drinker-vs-Occasional Drinker
6.797800E-01
Weekly Drinker-vs-Social Drinker
8.793600E-01
Occasional Drinker-vs-Social Drinker
3.390200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.594400E-01
Normal-vs-Grade 2
9.144200E-01
Normal-vs-Grade 3
8.387800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.721600E-01
Grade 1-vs-Grade 3
7.411400E-01
Grade 1-vs-Grade 4
8.594400E-01
Grade 2-vs-Grade 3
6.727600E-02
Grade 2-vs-Grade 4
9.144200E-01
Grade 3-vs-Grade 4
8.387800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.783400E-01
Normal-vs-NonDiabetic
6.963600E-01
Diabetic-vs-NonDiabetic
4.803800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.229410E-01
Normal-vs-NoPancreatitis
6.679000E-01
Pancreatitis-vs-NoPancreatitis
7.014400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.155600E-01
Normal-vs-N1
6.985200E-01
N0-vs-N1
7.870000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.509200E-01
Normal-vs-TP53-NonMutant
6.842400E-01
TP53-Mutant-vs-TP53-NonMutant
1.066570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
